Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Alteon's pimagedine progresses to phase III

Aug. 4, 1997

Crinone approved in U.S. for additional indication

Aug. 4, 1997

Ergoset improves metabolism in healthy obese women

Aug. 4, 1997

Novartis reports new NPY antagonists with selectivity for Y5 receptors

Aug. 1, 1997

Clinical trial of Lipitor for the reduction of cholesterol in women

July 31, 1997

Acute and subchronic effects of SR-58611A on glucose tolerance in mice

July 31, 1997

Troglitazone approved in the U.K.

July 31, 1997

Phase I comparison of CCKA agonist and CCK-8 for effects on satiety

July 31, 1997

Antiobesity drug therapy

July 31, 1997

Clinical pharmacokinetics, safety and efficacy of orlistat

July 31, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...